Free Trial

Evolent Health (EVH) Stock Price, News & Analysis

Evolent Health logo
$11.64 -0.15 (-1.27%)
Closing price 03:59 PM Eastern
Extended Trading
$11.58 -0.05 (-0.47%)
As of 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Evolent Health Stock (NYSE:EVH)

Key Stats

Today's Range
$11.54
$12.07
50-Day Range
$7.19
$11.79
52-Week Range
$7.06
$33.63
Volume
4.35 million shs
Average Volume
2.53 million shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.79
Consensus Rating
Buy

Company Overview

Evolent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
31st Percentile Overall Score

EVH MarketRank™: 

Evolent Health scored higher than 31% of companies evaluated by MarketBeat, and ranked 496th out of 653 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Evolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Evolent Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Evolent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Evolent Health are expected to decrease in the coming year, from $0.08 to ($0.29) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Evolent Health is -9.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Evolent Health is -9.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Evolent Health has a P/B Ratio of 1.34. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Evolent Health's valuation and earnings.
  • Percentage of Shares Shorted

    13.16% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Evolent Health has recently decreased by 12.77%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Evolent Health does not currently pay a dividend.

  • Dividend Growth

    Evolent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.16% of the float of Evolent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Evolent Health has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Evolent Health has recently decreased by 12.77%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Evolent Health has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Evolent Health this week, compared to 6 articles on an average week.
  • Search Interest

    Only 2 people have searched for EVH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Stock News Headlines

Evolent Health Inc. Cl A Financials | EVH | Barron's
These 7 Stocks for This Summer
Summer is almost Here! I would like to give you a special report that could help boost your portfolio this summer (and beyond). It’s called 7 Best Stocks to Own in Summer 2025. These are companies that not only thrive in the summer but are capable of generating juicy returns throughout the year. To get it, just click the link below… but don’t dally, this is a limited-time offer.
See More Headlines

EVH Stock Analysis - Frequently Asked Questions

Evolent Health's stock was trading at $11.25 on January 1st, 2025. Since then, EVH shares have increased by 3.5% and is now trading at $11.64.

Evolent Health, Inc (NYSE:EVH) posted its quarterly earnings data on Thursday, May, 8th. The technology company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by $0.02. Evolent Health's quarterly revenue was down 24.4% on a year-over-year basis.
Read the conference call transcript
.

Evolent Health (EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

Top institutional shareholders of Evolent Health include Salem Investment Counselors Inc. (0.28%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Diane Holder, Emily Ann Rafferty, Cheryl Scott, Mary Bridget Duffy and Brendan B Springstubb.
View institutional ownership trends
.

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Last Earnings
5/08/2025
Today
7/07/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
INTERNET SOFTWARE
Sub-Industry
Business Services
Current Symbol
NYSE:EVH
Employees
4,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$17.79
High Stock Price Target
$35.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+51.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
14 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
146.94
P/E Growth
N/A
Net Income
-$61.62 million
Pretax Margin
-4.56%

Debt

Sales & Book Value

Annual Sales
$2.55 billion
Cash Flow
$1.51 per share
Price / Cash Flow
7.77
Book Value
$8.70 per share
Price / Book
1.35

Miscellaneous

Free Float
115,522,000
Market Cap
$1.38 billion
Optionable
Optionable
Beta
1.01

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:EVH) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners